8-KRegulation FD

Elevance Health, Inc. 8-K Report, Regulation FD Disclosure (Jun 17, 2019)

Filed June 17, 2019For Securities:ELV

Summary

Elevance Health, Inc. (formerly Anthem, Inc.) filed this 8-K on June 17, 2019, primarily to disclose upcoming investor meetings where the company intended to reaffirm its full-year 2019 financial guidance. Management stated their expectation for net income to exceed $18.27 per share, including approximately $0.93 per share in unfavorable net items. Excluding these items, the adjusted net income guidance remained above $19.20 per share, consistent with prior disclosures and not accounting for any new adjustment items beyond those reported in Q1 2019. This filing also serves as a standard vehicle for forward-looking statements, highlighting the inherent risks and uncertainties associated with the company's business. Investors should note that the information provided in this 8-K is not considered "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934 and will not be incorporated into future SEC filings unless explicitly stated. The company detailed various risk factors, including regulatory changes, healthcare cost trends, provider contracts, competitive pressures, and potential litigation, which could impact future financial performance.

Key Highlights

  • 1Elevance Health (Anthem) reaffirmed its full-year 2019 net income guidance of greater than $18.27 per share.
  • 2The company expects approximately $0.93 per share in net unfavorable items for 2019.
  • 3Adjusted net income guidance for 2019 remains greater than $19.20 per share, excluding specified items.
  • 4The guidance does not incorporate any new adjustment items beyond those reported in the first quarter of 2019.
  • 5Company officers will discuss these projections with investors between June 18, 2019, and June 28, 2019.
  • 6The filing includes standard forward-looking statements and a comprehensive list of risk factors impacting the business.

Frequently Asked Questions

The primary purpose of this 8-K filing is to inform investors that Elevance Health officers will be meeting with them and will be reaffirming the company's previously issued financial guidance for the full year 2019. It also serves to reiterate the company's risk factors.

Elevance Health reaffirmed its expectation for full-year 2019 net income to be greater than $18.27 per share. Excluding approximately $0.93 per share in net unfavorable items, the adjusted net income guidance is expected to be greater than $19.20 per share.

No, the company explicitly stated that this guidance does not include any adjustment items beyond those that were already reported in their first quarter 2019 earnings release.

The 8-K filing includes a section detailing "FORWARD-LOOKING STATEMENTS" which lists numerous risks and uncertainties that could cause actual results to differ materially from projections. Investors are also urged to review the company's other SEC filings for a more comprehensive understanding of these risks.